載入...
Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease
BACKGROUND: A three-drug regimen (macrolide, ethambutol, and rifampicin) is recommended for the treatment of Mycobacterium avium complex pulmonary disease (MAC-PD). Although macrolide has proven efficacy, the role of ethambutol and rifampicin in patients without acquired immune deficiency syndrome i...
Na minha lista:
發表在: | BMC Pulm Med |
---|---|
Main Authors: | , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
BioMed Central
2019
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6849249/ https://ncbi.nlm.nih.gov/pubmed/31711459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-019-0982-8 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|